FDA Approves New Type of Drug, Ubrogepant (Ubrelvy), to Treat Migraines

MONDAY, Dec. 23, 2019 -- Migraine sufferers who cannot get relief from existing medications have a new treatment option, the U.S. Food and Drug Administration announced Monday. The pill, called ubrogepant (Ubrelvy) is for the immediate treatment...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news